Related Experiment Videos

Molecular basis of mild hyperphenylalaninaemia in Poland

C Zekanowski1, M Nowacka, B Cabalska

  • 1Department of Genetics, National Research Institute of Mother and Child, Warszawa, Poland.

Insights

Genetic mutations in the phenylalanine hydroxylase (PAH) gene cause hyperphenylalaninaemia (HPA). This study identified specific PAH mutations linked to mild HPA and mild phenylketonuria (PKU) phenotypes in Polish patients.

Area of Science:

  • Biochemistry
  • Genetics
  • Medical Genetics

Background:

  • Hyperphenylalaninaemia (HPA) encompasses a spectrum of metabolic disorders.
  • Mutations in the phenylalanine hydroxylase (PAH) gene are the primary cause of HPA.
  • Understanding genotype-phenotype correlations is crucial for managing HPA and mild phenylketonuria (PKU).

Purpose of the Study:

  • To identify specific mutations in the PAH gene responsible for mild forms of HPA.
  • To correlate distinct clinical phenotypes of HPA patients with their respective PAH genotypes.
  • To aid in the molecular differential diagnosis of PAH deficiency in Poland.

Main Methods:

  • Analysis of PAH gene mutations in patients presenting with mild HPA phenotypes.
  • Genotyping of patients to identify specific mutation variants.
  • Correlation of identified genotypes with observed clinical presentations.

Main Results:

  • Four specific "mild" PAH mutations, including A403V and R297H, were exclusively found in patients with mild hyperphenylalaninaemia (MHP).
  • Mutations A104D, R243Q, R241H, and Y414C were exclusively detected in patients with mild phenylketonuria (mild PKU).
  • Distinct PAH genotypes were associated with specific mild HPA and mild PKU phenotypes.

Conclusions:

  • The study successfully identified PAH mutations linked to mild HPA and mild PKU.
  • Genotype-phenotype correlations provide valuable insights for diagnosing PAH deficiency.
  • These findings support the establishment of a molecular diagnostic approach for PAH deficiency in Poland.

Related Concept Videos